Skip to main content

An experimental imaging dose estimation method for the phase-II proton CT scanner

In brief

Proton CT dose estimates matched chamber readings within 1.8% in standard phantom

A new method using proton tracks and computer simulations estimated imaging dose within 1.8% of ionization chamber measurements in a standard dose phantom. In a head phantom, it underestimated dose by 4.6% for a single projection and 6.7% for a full scan. The workflow supports dose evaluation, but accuracy in different phantoms remains an important consideration.

Journal
Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) (Q2)
Published
17 November 2026
Study design
Unclassified
Evidence level
Level 5, Expert Opinion (CEBM 5)
Authors
Lei Chen, Robert P Johnson, Mark Pankuch, Jonathan Bortfeldt, Katia Parodi, Reinhard Schulte, et al.
PMID
43044300
DOI
10.1016/j.ejmp.2026.107223

Why clinicians should know about it

  • Picked for Medical Physics (top studies of the week, 22 November 2026): Proton CT imaging dose measured and validated against chambers

Abstract

PURPOSE: Proton computed tomography (pCT) improves range accuracy in proton therapy by directly mapping proton stopping power relative to water (RSP). Imaging dose remains a crucial factor in determining the feasibility of daily image guidance. This study presents an experimental methodology for estimating imaging dose in the phase-II pCT scanner, utilizing phase space data recorded at the front tracker to eliminate phantom-specific corrections. The estimated doses are validated against ionization chamber (IC) measurements. METHODS: Dose measurements were conducted at multiple locations and angles within two phantoms, with data acquisition triggered by either the front trackers or the energy detector. Baseline scans were also performed without phantoms. Monte Carlo (MC) simulations were used to estimate imaging dose in single projections and full scans. Eight front-tracker-triggered baseline datasets were processed for proton track reconstruction and fluence estimation. After assessing inter-run variability, phase space files were averaged to generate an input source for MC simulations. The simulated imaging doses were renormalized to the averaged datasets and quantitatively compared against IC measurements. RESULTS: Analyzed proton track numbers exhibited consistency across datasets, with coefficients of variation below 2.0%. Estimated doses agreed with IC measurements within ±1.8% for the CTDI phantom; head phantom underestimated -4.6% (single projection) and -6.7% (full scan). Uncertainties from multiple measurements remained below 1.9%. CONCLUSION: This study introduces a reliable workflow for imaging dose estimation in the phase-II pCT scanner. The approach demonstrates satisfactory agreement with IC measurements, supporting its feasibility for evaluating imaging dose in image-guided and adaptive proton therapy.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.